Видео ютуба по тегу Immune-Oncology

Oxford Cancer Theme Video - Immuno-oncology
Oxford Cancer Theme Video - Immuno-oncology
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers
Deciphering Immuno-Oncology: Targeting Cellular Mechanisms of the Tumor Immune Response
Deciphering Immuno-Oncology: Targeting Cellular Mechanisms of the Tumor Immune Response
Cancer Immune Checkpoint Inhibitors
Cancer Immune Checkpoint Inhibitors
An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar
An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar
Cancer Immunotherapy
Cancer Immunotherapy
Cancer Vaccines - Dr. Keith L. Knutson Ph.D. - 60
Cancer Vaccines - Dr. Keith L. Knutson Ph.D. - 60
Decoding cancer immunology: Hunting hidden tumours
Decoding cancer immunology: Hunting hidden tumours
Immuno-oncology: Cold to Hot Tumours
Immuno-oncology: Cold to Hot Tumours
Harnessing the Immune System to Fight Cancer
Harnessing the Immune System to Fight Cancer
OICR Mondays: 'Immuno-oncology — moving beyond the asymptote'
OICR Mondays: 'Immuno-oncology — moving beyond the asymptote'
What is immuno-oncology treatment for cancer?
What is immuno-oncology treatment for cancer?
Immune Checkpoint Inhibitors, The Next Generation Cancer Therapy - Creative Biolabs
Immune Checkpoint Inhibitors, The Next Generation Cancer Therapy - Creative Biolabs
Update on Immuno-Oncology Biomarkers
Update on Immuno-Oncology Biomarkers
Expanding the Benefits of Immuno-Oncology Through Novel Rational Targets and Combinations
Expanding the Benefits of Immuno-Oncology Through Novel Rational Targets and Combinations
T cell Take Down: Researchers discover how cancer cells manipulate the immune system
T cell Take Down: Researchers discover how cancer cells manipulate the immune system
Immunotherapy: How the Immune System Fights Cancer?
Immunotherapy: How the Immune System Fights Cancer?
Developing a portfolio of first-in-class immune-oncology antibodies
Developing a portfolio of first-in-class immune-oncology antibodies